99 related articles for article (PubMed ID: 21396853)
1. Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
George GP; Mandal RK; Kesarwani P; Sankhwar SN; Mandhani A; Mittal RD
Urol Oncol; 2012; 30(6):781-9. PubMed ID: 21396853
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the caspase-8 gene and the risk of lung cancer.
Son JW; Kang HK; Chae MH; Choi JE; Park JM; Lee WK; Kim CH; Kim DS; Kam S; Kang YM; Park JY
Cancer Genet Cytogenet; 2006 Sep; 169(2):121-7. PubMed ID: 16938569
[TBL] [Abstract][Full Text] [Related]
3. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
4. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
5. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
6. Association between Caspase-9 promoter region polymorphisms and discogenic low back pain.
Guo TM; Liu M; Zhang YG; Guo WT; Wu SX
Connect Tissue Res; 2011 Apr; 52(2):133-8. PubMed ID: 21091209
[TBL] [Abstract][Full Text] [Related]
7. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer.
Kesarwani P; Mandal RK; Maheshwari R; Mittal RD
BJU Int; 2011 Feb; 107(3):471-6. PubMed ID: 20804486
[TBL] [Abstract][Full Text] [Related]
8. CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Surg Oncol; 2011 Jun; 103(7):716-23. PubMed ID: 21308686
[TBL] [Abstract][Full Text] [Related]
9. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variants of Caspase genes (8 & 3) in the risk prediction of Coronary Artery Disease.
Gundapaneni KK; Shyamala N; Galimudi RK; Kupsal K; Gantala SR; Padala C; Gunda P; Tupurani MA; Puranam K; Sahu SK; Hanumanth SR
Gene; 2017 Sep; 627():278-283. PubMed ID: 28633917
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
12. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
13. Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
Mittal RD; Srivastava P; Mittal T; Verma A; Jaiswal PK; Singh V; Mandal RK; Mandhani A
Eur J Surg Oncol; 2011 Aug; 37(8):727-33. PubMed ID: 21700414
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Coinac I; Bogdanova N; Dubrowinskaja N; Turmanov N; Haubold S; Schürmann P; Imkamp F; von Klot C; Merseburger AS; Machtens S; Bremer M; Hillemanns P; Kuczyk MA; Karstens JH; Serth J; Dörk T
Urol Oncol; 2013 Jan; 31(1):74-81. PubMed ID: 21396839
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
Kesarwani P; Mandhani A; Mittal RD
J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
18. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
19. Association between CASP-8 gene polymorphisms and cancer risk in some Asian population based on a HuGE review and meta-analysis.
Zhang YJ; Zhong XP; Chen Y; Liu SR; Wu G; Liu YF
Genet Mol Res; 2013 Feb; 12(4):6466-76. PubMed ID: 23479148
[TBL] [Abstract][Full Text] [Related]
20. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]